Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992–2008)

International Journal of Microbiology - Tập 2010 - Trang 1-15 - 2010
Matthias Imöhl1, Ralf René Reinert1,2, Mark van der Linden1
1National Reference Center for Streptococci, Institute of Medical Microbiology, University Hospital (RWTH), 52074 Aachen, Germany
2Wyeth Vaccines Research, Coeur Défense-Tour A, 110 esplanade du Général de Gaulle, 92931 Paris la Défense Cedex, France

Tóm tắt

Nationwide surveillance of invasive pneumococcal disease has been conducted in Germany since 1992. From 1992 to 2008, a total of 12,137 isolates from invasive pneumococcal disease were collected. Data on serotypes were available for 9,394 invasive isolates. The leading serotypes were serotypes 14 (16.5%), 3 (8.0%), 7F (7.6%), 1 (7.3%), and 23F (6.0%). Variations in serotype distribution over the years are particularly extensive, especially concerning serotype 14 (min 7.4%, max 33.5%) with the highest percentages among the isolates serotyped from around 1997 to 2006. Serotypes 1 and 7F increased over the last decade. No increase was observed concerning serotype 19A. Higher pneumococcal conjugate vaccine coverages were observed among children (7v, 57.3%; 10v, 72.8%; 13v, 83.5%) than among adults (7v, 39.9%; 10v, 55.5%; 13v, 73.5%). The temporal variations in serotype distribution have to be kept in mind when interpreting vaccine coverages reported in epidemiological studies.

Từ khóa


Tài liệu tham khảo

1981, Reviews of Infectious Diseases, 3, 183, 10.1093/clinids/3.2.183

10.1086/341896

10.1128/JCM.02321-07

10.1128/JCM.01454-08

10.1016/j.ijmm.2004.04.004

10.1086/432015

10.1016/j.ijmm.2009.05.005

1995, Clinical Infectious Diseases, 21, 1398, 10.1093/clinids/21.6.1398

2002, Journal of Antimicrobial Chemotherapy, 49, 61, 10.1093/jac/49.1.61

10.1086/313984

10.1111/j.1469-0691.2005.01282.x

1987, European Journal of Clinical Microbiology, 6, 696, 10.1007/BF02013080

10.1016/j.vaccine.2008.04.031

10.1099/jmm.0.47690-0

10.1093/jac/dkm435

10.1128/CDLI.9.2.358-365.2002

10.1111/j.1469-0691.2009.02895.x

1998, Brazilian Journal of Infectious Diseases, 2, 90

1994, Journal of Clinical Microbiology, 32, 1606, 10.1128/JCM.32.6.1606-1607.1994

10.1056/NEJM200012283432603

1985, Immunitat und Infektion, 13, 99

10.1086/521626

10.1111/j.1469-0691.2009.02724.x

2002, European Journal of Pediatrics, 161, S135, 10.1007/s00431-002-1066-x

10.1016/j.vaccine.2009.04.057

10.1111/j.1469-0691.2008.02031.x

10.1111/j.1574-695X.2007.00283.x

2008, Euro Surveillance, 13

10.1089/mdr.2008.0782

10.1111/j.1469-0691.2006.01544.x

10.1086/313608

2006, Epidemiolgisches Bulletin, 30, 255